Toth Financial Advisory Corp Sells 18,698 Shares of CVS Health Co. (NYSE:CVS)

Toth Financial Advisory Corp decreased its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 27.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,408 shares of the pharmacy operator's stock after selling 18,698 shares during the quarter. Toth Financial Advisory Corp's holdings in CVS Health were worth $3,044,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Deerfield Management Company L.P. Series C acquired a new stake in CVS Health during the 2nd quarter worth approximately $57,584,000. CX Institutional lifted its holdings in shares of CVS Health by 698.0% during the third quarter. CX Institutional now owns 74,609 shares of the pharmacy operator's stock worth $4,691,000 after buying an additional 65,259 shares in the last quarter. Susquehanna Fundamental Investments LLC grew its stake in shares of CVS Health by 27.9% in the second quarter. Susquehanna Fundamental Investments LLC now owns 665,451 shares of the pharmacy operator's stock valued at $39,302,000 after acquiring an additional 145,158 shares in the last quarter. Steph & Co. increased its position in CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator's stock worth $35,000 after acquiring an additional 288 shares during the period. Finally, First Hawaiian Bank raised its stake in CVS Health by 30.1% in the 2nd quarter. First Hawaiian Bank now owns 100,302 shares of the pharmacy operator's stock worth $5,924,000 after purchasing an additional 23,213 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CVS has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft dropped their price target on shares of CVS Health from $64.00 to $63.00 and set a "hold" rating for the company in a research report on Friday, August 9th. Truist Financial upped their target price on CVS Health from $66.00 to $76.00 and gave the company a "buy" rating in a research report on Friday, October 11th. Barclays upgraded CVS Health from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $63.00 to $82.00 in a research report on Thursday, October 10th. Evercore ISI increased their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 8th. Finally, Wells Fargo & Company boosted their target price on shares of CVS Health from $60.00 to $61.00 and gave the company an "equal weight" rating in a research report on Monday, August 12th. Nine analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $75.26.

CVS Health Trading Down 3.6 %

NYSE:CVS traded down $2.16 during mid-day trading on Monday, hitting $58.18. 13,570,373 shares of the company's stock were exchanged, compared to its average volume of 11,239,877. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $73.04 billion, a P/E ratio of 10.22, a PEG ratio of 0.93 and a beta of 0.54. The company has a 50 day simple moving average of $59.85 and a 200-day simple moving average of $60.32.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts' consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. CVS Health's revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.21 earnings per share. As a group, research analysts expect that CVS Health Co. will post 6.51 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.57%. The ex-dividend date is Monday, October 21st. CVS Health's dividend payout ratio is currently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.